Vida Ventures Advisors, LLC
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed July 10, 2024), Vida Ventures Advisors, LLC reported 5 stock positions worth $91.4 million. Its top holding was Centessa Pharmaceuticals (CNTA) at 38.8% of the portfolio, followed by Kyverna Therapeutics (KYTX, 37.1%) and Dyne Therapeutics (DYN, 15.7%). Its holdings were unchanged from Q1 2024.
- Most Recent 13F
- Q3 2025
- Location
- BOSTON, MA
- CIK
- 0001831423
- Portfolio Value
- $91.4M (Q2 2024)
- SEC Filing
- 0000950123-24-006464 ↗ filed Jul 10, 2024
Holdings Value
Holdings 5 stocks · $91.4M
| CNTA Centessa Pharmaceuticals Ltd. | 38.83% | 3,931,818 | $35.5M | No change |
| KYTX Kyverna Therapeutics Inc. | 37.11% | 4,523,924 | $33.9M | No change |
| DYN Dyne Therapeutics Inc. | 15.73% | 407,499 | $14.4M | No change |
| ALLO Allogene Therapeutics Inc. | 4.58% | 1,798,163 | $4.2M | No change |
| KRON Kronos Bio Inc. | 3.75% | 2,765,314 | $3.4M | No change |
Portfolio Sells Q1 2024 → Q2 2024
| None this quarter. | |||
Portfolio Buys Q1 2024 → Q2 2024
| None this quarter. | |||